Trained immunity in viral infections, Alzheimer’s disease and multiple sclerosis

Type I interferon presents in such as Alzheimer’s disease (AD) and multiple sclerosis (MS), where viral infections are known to increase symptomatic burden – and a the same time, we know, that Type I interferon (IFN-I) signalling represents a major target for modulation in a virus’ bid for latency.